The landscape of dementia analysis has progressed dramatically with the appearance of subtle biomarkers, together with amyloid PET scans, tau imaging, and blood-dependent assessments that will detect Alzheimer's pathology many years before symptoms arise. Even though these technological developments represent extraordinary progress in comprehending neurodegenerative diseases, they hav... https://peters641mwf0.wikiconversation.com/user